Journal of Neurology

, Volume 257, Issue 9, pp 1457–1464

Facioscapulohumeral muscular dystrophy: a prospective study of weakness and functional impairment

Original Communication


Only isolated prospective studies have attempted to chart the natural history of facioascapulohumeral muscular dystrophy (FSHD), a benign myopathy with notoriously variable clinical manifestations and progression. This 10-year prospective study was performed to document by simple clinical methods the natural history of 16 patients with moderately advanced FSHD. Limb strength was evaluated by the bedside manual muscle test. Global weakness was documented as a composite average muscle score (AMS). Limb function was evaluated by a non-linear grading system of important functional milestones. A scale of activities of daily living (ADL) was used to assess disability across multiple functional domains in a home environment. Six-monthly evaluations determined a linear deterioration of the mean AMS that reached statistical significance from baseline at the 5-year interval. Half of patients showed a functional decline of the arms by one grade. All patients maintained useful hand function. Three quarters of patients suffered functional decline of the legs, commonly by one grade. All patients remained ambulant. Interval analyses showed a linear deterioration of the mean ADL score that reached statistical significance from baseline at the 5-year interval. Functional deterioration was mostly due to impaired shoulder girdle activities. This study of a relatively homogeneous subgroup of FSHD patients showed a predictable rate of clinical progression in a muscle disease with a notoriously variable clinical presentation and outcome. Natural history data obtained in this study could serve as positive controls for future therapeutic trials in this patient population. The chosen clinical parameters proved useful tools for charting clinical disease progression. Functional tests proved advantageous, because decline was based partly on patient self-reports, thereby improving time and cost effectiveness.


Facioscapulohumeral muscular dystrophy Prospective study Natural history Weakness Functional impairment 


  1. 1.
    Appel V, Stewart SS, Smith G, Appel SH (1987) A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 22:328–333CrossRefPubMedGoogle Scholar
  2. 2.
    Bradley WG (1979) The limb-girdle syndromes. In: Vinken PJ, Bruyn GH (eds) Handbook of clinical neurology, vol 40. Elsevier/North Holland, Amsterdam, pp 433–469Google Scholar
  3. 3.
    Brooke MH (1990) Introductory comments on disease-specific tests. Muscle Nerve 13(Suppl):S26–S29Google Scholar
  4. 4.
    Brooke MH (1990) Introductory comments on disease-specific tests. Muscle Nerve 13(Suppl):S38–S39CrossRefPubMedGoogle Scholar
  5. 5.
    Brooke MH, Fenichel GM, Griggs RC et al (1989) Duchenne muscular dystrophy: pattern of clinical progression and effects on supportive therapy. Neurology 39:475–481PubMedGoogle Scholar
  6. 6.
    Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP, Province MA (1983) Clinical investigation in Duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural history. Muscle Nerve 6:91–103CrossRefPubMedGoogle Scholar
  7. 7.
    Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ (1981) Clinical trial in Duchenne dystrophy. 1. The design of the protocol. Muscle Nerve 4:186–197CrossRefPubMedGoogle Scholar
  8. 8.
    Bunch WH, Siegel IM (1993) Scapulothoracic arthrodesis in facioscapulohumeral muscular dystrophy. Review of seventeen procedures with three to twenty-one-year follow-up. J Bone Joint Surg Am 75:372–376PubMedGoogle Scholar
  9. 9.
    Carroll JE (1979) Facioscapulohumeral and scapuloperoneal syndromes. In: Vinken PJ, Bruyn GH (eds) Handbook of clinical neurology vol 40. Elsevier/North Holland, Amsterdam, pp 415–431Google Scholar
  10. 10.
    Cuthbert SC, Goodheart GJ (2007) On the reliability and validity of manual muscle testing: a literature review. Chiropr Osteopat 15:4–27CrossRefPubMedGoogle Scholar
  11. 11.
    Florence JM, Pandya S, King WM, Robison JD, Baty J, Miller JP, Schierbecker J, Signore LC (1992) Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne’s muscular dystrophy. Phys Ther 72:115–126PubMedGoogle Scholar
  12. 12.
    Gresham GE, Phillips TF, Labi ML (1980) ADL status in stroke: relative merits of three standard indices. Arch Phys Med Rehabil 61:355–358PubMedGoogle Scholar
  13. 13.
    Hasselkus BR, Safrit MJ (1976) Measurement in occupational therapy. Am J Occup Ther 30:429–437PubMedGoogle Scholar
  14. 14.
    Kasakov V, Rudenko DI (1995) Clinical variability in facioscapulohumeral muscular dystrophy in Russia. Muscle Nerve 18(Suppl 2):S85–S95CrossRefGoogle Scholar
  15. 15.
    Kilmer DD, Abresch RT, McCrory MA, Carter GT, Fowler WM, Johnson ER, McDonald CM (1995) Profiles in neuromuscular diseases: facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil 74(Suppl):S131–S139CrossRefPubMedGoogle Scholar
  16. 16.
    Korner-Bitensky N, Wood-Dauphinee S (1995) Barthel Index information elicited over the telephone. Is it reliable? Am J Phys Med Rehabil 74:9–18CrossRefPubMedGoogle Scholar
  17. 17.
    Lue YJ, Chen SS (2000) Strength and functional performance of patients with limb girdle muscular dystrophy. Kaohsiung J Med Sci 16:83–90PubMedGoogle Scholar
  18. 18.
    Lue YJ, Su CY, Yang RC, Su WL, Lu YM, Lin RF, Chen SS (2006) Development and validation of muscular dystrophy-specific functional rating scale. Clin Rehabil 20:804–817PubMedGoogle Scholar
  19. 19.
    Lunt PW, Jardine PE, Koch MC, Maynard J, Osborn M, Williams M, Harper PS, Upadhyaya M (1995) Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD). Hum Mol Gene 4:951–958CrossRefGoogle Scholar
  20. 20.
    Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel Index. Md Med J 14:61–65Google Scholar
  21. 21.
    Marino M, Nicholas JA, Gleim GW, Rosenthal P, Nicholas SJ (1982) The efficacy of manual assessment of muscle strength using a new device. Am J Sports Med 10:360–364CrossRefPubMedGoogle Scholar
  22. 22.
    Medical Research Council (1976) Aids to the investigation of peripheral nerve injuries. Her Majesty’s Stationary Office, LondonGoogle Scholar
  23. 23.
    Mendell JR, Florence J (1990) Manual muscle testing. Muscle Nerve 13(Suppl):S16–S20CrossRefPubMedGoogle Scholar
  24. 24.
    Mendell JR, Province MA, Moxley RT et al (1987) Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controls. Arch Neurol 44:808–811PubMedGoogle Scholar
  25. 25.
    Moxley RT (1990) Functional testing. Muscle Nerve 13(Suppl):S26–S29CrossRefPubMedGoogle Scholar
  26. 26.
    Munsat TL (1990) Clinical trials in neuromuscular disease. Muscle Nerve 13 (Suppl):S3–S6 27. Munsat TL (1994) Facioscapulohumeral disease and the scapuloperoneal syndrome. In: Engel AG, Franzini-Armstrong C (eds) Myology. McGraw-Hill, New York, pp 1220–1232Google Scholar
  27. 27.
    Munsat TL, Andres PL, Finison L, Conlon T, Thibodeau L (1988) The natural history of motorneuron loss in amyotrophic lateral sclerosis. Neurology 38:409–413PubMedGoogle Scholar
  28. 28.
    Padberg GW (1982) Facioscapulohumeral disease. Doctoral thesis, University of Leiden, Intercontinental GraphicsGoogle Scholar
  29. 29.
    Padberg GW, Frants RR, Brouner OF, Wijmega C, Bakker E, Sandkuijl LA (1995) Facioscapulohumeral muscular dystrophy in the Dutch Population. Muscle Nerve 18(Suppl 2):S81–S84CrossRefGoogle Scholar
  30. 30.
    Padberg GW, Lunt PW, Koch M, Fardeau M (1991) Diagnostic criteria for facioscapulohumeral dystrophy. Neuromuscul Disord 1:231–234CrossRefPubMedGoogle Scholar
  31. 31.
    Personius KE, Pandya S, King W, Tawil R, McDermott MP (1994) Facioscapulo- humeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. Phys Ther 74:253–263PubMedGoogle Scholar
  32. 32.
    Ricci E, Galluzzi G, Deidda G et al (1999) Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of Kpni repeats at the 4q35 locus and clinical phenotype. Ann Neurol 45:751–757CrossRefPubMedGoogle Scholar
  33. 33.
    Shinar D, Gross CR, Bronstein KS et al (1987) Reliability of the activities of daily living scale and its use in telephone interview. Arch Phys Med Rehabil 68:723–728PubMedGoogle Scholar
  34. 34.
    Tawil R, Figlewicz DA, Griggs RC, Weiffenbach B, the FSH Consortium (1998) Facioscapulohumeral dystrophy. A distinct regional myopathy with a novel molecular pathogenesis. Ann Neurol 43:279–282CrossRefPubMedGoogle Scholar
  35. 35.
    Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, McDermott M, King W, Weiffenbach B, Figlewicz D (1996) Evidence for anticipation and association of deletion size with the severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. Ann Neurol 39:744–748CrossRefPubMedGoogle Scholar
  36. 36.
    Tawil R, van der Maarel SM (2006) Facioscapulohumeral muscular dystrophy. Muscle Nerve 4:1–15CrossRefGoogle Scholar
  37. 37.
    The FSH-DY group (1997) A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy. Neurology 48:38–46Google Scholar
  38. 38.
    Tindall RSA, Rollins JA, Phillips JT, Greenlee RG, Wells L, Belendink G (1987) Preliminary results of a double blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis. N Engl J Med 316:719–724CrossRefPubMedGoogle Scholar
  39. 39.
    Twyman RS, Harper GD, Edgar MA (1996) Thoracoscapular fusion in facioscapulohumeral muscular dystrophy: clinical review of a new surgical method. J Shoulder Elbow Surg 5:201–205CrossRefPubMedGoogle Scholar
  40. 40.
    Vignos PJ, Spencer GE, Archibald KC (1963) Management of progressive muscular dystrophy in childhood. JAMA 84:89–96Google Scholar
  41. 41.
    Wadsworth CT, Krishnan R, Sear M, Harrold J, Nielsen DH (1987) Intrarater reliability of manual muscle testing and hand-held dynametric muscle testing. Phys Ther 67:1342–1347PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Department of NeurologyUniversity of PretoriaPretoriaSouth Africa
  2. 2.Department of Rehabilitation MedicineUniversity of PretoriaPretoriaSouth Africa
  3. 3.Department of Neurology and Neuroscience, Cornell University Medical CollegeNew York Presbyterian HospitalNew YorkUSA

Personalised recommendations